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1. Introduction 
The ankylosing spondylitis (AS) (Bechterew’s disease) is a chronic inflammatory 
rheumatoid disease with predilection in the axial structures. Often the first clinical 
indication of the condition is lumbo-sacral pain and discomfort with limited range of 
motion. The prevalence in Caucasian population is 1-2% with slight male predominance [1, 
31, and 32]. Peak age of onset is between 20–30 years, with an average 5–6-year delay in 
diagnosis reported in the literature. A familial tendency has been strongly suggested by 
recent evidence. Immunologic activity is suggested by the presence of histocompatibility 
antigen HLA-B27 (in more than 90 percent of patients with this disease) and circulating 
immune complexes. 
The disease course, although highly variable, will progress to severe disability in one third 
of patients. Progressive synovial changes eventually involve all of the axial joints including 
the temporomandibular joint [2]. Literature shows the temporomandibular joint (TMJ) is 
involved in 4% to 32% of cases [1, 31, and 32]. The severity of the disease may range from 
sore TMJ to complete ankylosis leading to restricted mouth opening.  Ankylosis of the TMJ 
is exceptional; the involvement of TMJ has not been very well investigated. This chapter 
describes the incidence, clinical features, pathophysiology, signs, symptoms and current 
management of TMJ ankylosing spondylitis 
2. Anatomy of TMJ 
The Temporo-Mandibular joint (TMJ) is the joint of the jaw and is frequently referred to as 
TMJ [3]. There are two TMJs, one on either side, working in unison. The name is derived 
from the two bones which form the joint: the upper temporal bone which is part of the 
cranium (skull), and the lower jaw bone called the mandible. The unique feature of the TMJs 
is the articular disc. The disc is composed of fibrocartilagenous tissue (like the firm and 
flexible elastic cartilage of the ear) which is positioned between the two bones that form the 
joint. The TMJs are one of the only synovial joints in the human body with an articular disc, 
another being the sternoclavicular joint. The disc divides each joint into two. The lower joint 
compartment formed by the mandible and the articular disc is involved in rotational 
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movement—this is the initial movement of the jaw when the mouth opens. The upper joint 
compartment formed by the articular disk and the temporal bone is involved in translational 
movement—this is the secondary gliding motion of the jaw as it is opened widely.  
The part of the mandible which mates to the under-surface of the disc is the condyle and the 




The TMJ is a hinge and gliding joint and is the most constantly used joint in the body. The 
round upper end of the lower jaw, or the movable portion of the joint, is called the condyle; 
the socket is called the articular fossa. Between the condyle and the fossa is a disk made of 
cartilage that acts as a cushion to absorb stress and allows the condyle to move easily when 
the mouth opens and closes. 
3. Pathophysiology 
Ankylosing spondylitis (AS) is a systemic rheumatic disease, meaning it affects the entire 
body. Approximately 90% of AS patients express the HLA-B27 genotype, meaning there is a 
strong genetic association. However, only 5% of individuals with the HLA-B27 genotype 
contract the disease. Tumor necrosis factor-alpha (TNF α) and Interleukin-1(IL-1) are also 
implicated in ankylosing spondylitis. Autoantibodies specific for AS have not been 
identified. Antineutrophil cytoplasmic antibodies (ANCA) are associated with AS, but do 
not correlate with disease severity. 
TMJ involvement in patients with ankylosing spondylitis has been described previously in 
very few journals[16] Its reported frequency varies from 1% to 35%, depending on the 
diagnostic criteria, the population studied, and the tools used to assess TMJ 
involvement[17]. However, the majority of the reports included patients with long lasting 
ankylosing spondylitis from tertiary care centres, and while they focus on TMJ involvement, 
little information on the characteristics of the ankylosing spondylitis is given. 
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Fig. 2. Lateral view of TMJ (Courtesy: Gray’s anatomy). 
 
Fig. 3. Sagittal section of the articulation of the mandible. (Courtesy: Gray’s anatomy). 
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Fig. 4. CT scan shows complete ankylosis of bilateral TMJs in AS (marked areas showing 
reduced joint space and fusion of condylar head with glenoid fossa). 
4. Signs and symptoms [4, 18] 
 Chronic pain in the muscles of mastication described as a dull ache, typically unilateral 
may become bilateral in later stages. 
 Pain may radiate to the ear and jaw and is worsened with chewing  
 Headache and/or neck ache: In some cases, patients may complain of headache without 
localized pain in the temporomandibular joint.  
 A bite that feels uncomfortable or different from usual  
 Associated neck, shoulder, and back pain  
 Increasing pain over the course of the day  
 Limitation of jaw opening (normal range is at least 40 mm as measured from lower to 
upper anterior teeth) worsens as the disease progresses.  
 Clicking or popping in the TMJ 
 Tenderness to palpation of the TMJ  
5. Diagnosis 
This problem is diagnosed through a combination of clinical history, examination, imaging 
and the finding of HLA-B27 in the blood. 
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Fig. 5.  
Radiographic findings in TMJ depend on the etiology, in cases of AS, rheumatoid arthritis 
and seronegative spondyloarthropathies, plain films show erosions, osteophytes, 
subchondral bony sclerosis, and condylar-glenoid fossa remodeling[1].It is diffcult to to 
differntiate AS of TMJ with other degenarative conditions affecting this joint as there is 
significant correlation between  the radilogical findings of AS and other degenarative 
disorders[19]CT scans can explore both bony structures and muscular soft tissues. Of 
interest, there is utility with cone beam computed tomography (CBCT). The patient is 
scanned with the mouth open and closed. Specifically, CBCT can aid in the diagnosis of this 
condition along with history and physical examination. 
Magnetic resonance imaging (MRI) is now clearly established as a sensitive and specific tool 
to detect sacroiliitis [20] but minimal literature found on MRI sensitivity of TMJs in AS 
hence MRI should be used as the study of choice if TMJ articular or meniscal pathology is 
suspected and an endoscopic or surgical procedure is contemplated. 
Diagnostic arthroscopy is an invasive diagnostic approach and should be used mainly in 
patients suffering from internal TMJ derangements recalcitrant to conservative 
measures.TMJ can be approached via pre auricular incisions.  
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The treatment modalities mainly aim for relief of the symptoms and may be to prevent the 
progression of the disease [21]. The management of AS includes non-pharmacological, 
pharmacological, invasive and surgical interventions that should be tailored to each 
patient's disease manifestations, current symptoms, clinical findings and prognostic 
indicators [22]. The non-surgical treatment of temporomandibular disorder secondary to AS 
continues to be the most effective way of managing over 80 per cent of patients who present 
with symptoms of temporomandibular pain and dysfunction. Non-steroidal anti-
inflammatory drugs (NSAIDs) are recommended as first-line pharmacological treatment.  
7. Non-pharmacological treatment 
Non-pharmacological treatment of AS  includes fabrication of intra-oral splint,physiothery 
and  patient education.The most recent systematic review of physiotherapy for AS reviewed 
six randomised controlled trials (RCTs), showing that home exercise improved function in 
the short term compared with no intervention.  
Fabrication and insertion of an Intra-oral Orthotic (also known as splint or bite-gaurd): 
The purpose of these Orthotics, which may be fitted to either the upper or lower jaws, and 
in some cases to both, is to re-position the condyle head in the joint space to a more normal 
position, thereby relieving the stresses, and pressures, being placed on the tissues of the 
joints, and their related supporting structures allowing them to heal. 
Physiotherapy Therapy: These treatments might include Ultra-sound, TENS 
(transcutaneous electrical nerve stimulation) and home exercises. 
Ultrasound therapy is part of a physical therapy treatment using sound waves at a 
remarkably exorbitant frequency to penetrate the skin deep to the soft tissue of painful area. 
It involves employing a hand held probe provided a rounded make every effort which is 
attached to an ultrasound machine. A gel would be rubbed onto the skin and the probe head 
will be moved over the affected area in small circular movements. The high-frequency 
(ultrasonic) waves are produced by vibration on the run of the probe. The waves travel with 
the skin bringing about vibration to the tissue in the affected area. The vibration causes a 
heating up of the tissue that has a beneficial effect on the TMJ. The ultrasound therapy is 
safe when administered by a professional or person who has had training as it can have its 
dangers of skin burns.  
TENS in which a low voltage, low amperage current is applied to the preauricular region 
which is to relax the masticatory muscles, which are in a state of hyperactivity, fatigue or in 
spasm secondary to pain. It is like an electronic massage of the facial muscles. 
In exercise rehabilitation program, patient has to roll back the tongue to touch the roof of the 
mouth and asked to open and close the jaw by holding the tongue in same position. In 
another technique patient is asked to slowly open and close the mouth by keeping the palm 
of the hand against chin with gentle pressure. These exercises mainly aid in improving the 
mouth opening and to strengthen the muscles of mastication and TMJ ligaments. 
Patient education: has been shown to have short term benefit for function in AS in one 
controlled trial. There are no studies examining the effect of education on pain. Education 
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and behavioural therapy have, however, been shown to be beneficial for other outcomes 
such as motivation and anxiety. Patient associations and self help groups have not been 
studied for their effect on pain or functional outcomes. 
8. The pharmacological management 
The pharmacological management of AS of TMJ is essentially same as general management 
of AS which include Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Coxibs, and 
Corticosteroids. Literature also shows use of Disease-Modifying Antirheumatic Drugs 
(DMRDs) and anti-tumour necrosis factor (TNF) agents are recommended in the case of 
NSAID failure. There is insufficient evidence to support or not support the effectiveness of 
the reported drugs for the management of pain due TMD (Temporo-Mandibular Disorders). 
There is a need for high quality RCTs to derive evidence of the effectiveness of 
pharmacological interventions to treat pain associated with TMD [23] However it has been 
noticed that most patients respond well to medications given to reduce pain and 
inflammation, combined with mouth opening exercises to maintain adequate mouth 
opening and strengthen muscles of mastication to counteract possible ankylosis. 
9. The surgical management 
The surgical management is indicated in patients with marked trismus (decreased mouth 
opening) and in case of failure of other non surgical modalities. The surgical treatment may 
include injection of steroid, joint lavage and total joint replacement. TMJ intra-articular 
steroid injections use 0.5-1ml of Triamcinolone acetate or methyl prednilosone which is 
mixed with normal saline. These injections can be performed under local anaesthesia or 
general anaesthesia. Many patients reported quick relief of symptoms from steroid 
injections [24, 25] and joint lavage. 
Total joint replacement is considered as a last resort if the other treatment modalities fail. 
The first TMJ total joint replacement was performed about twenty years ago [26]. The 
principles, which were learned in total hip and knee replacement, have been successfully 
applied to the TMJ. Prosthetic replacement of the TMJ is a procedure that has undergone a 
technological revolution over the last decade. In spite of the high frequency of TMJ 
involvement, ankylosis secondary to AS seems to seldom ensue, and relatively few patients 
develop such severe degenerative TMJ disease that they require total joint replacement. This 
is reflected in the paucity of literature on the topic, with approximately 11 cases reported 
worldwide involving the TMJs bilaterally [8, 26, and 27].   
However, when the TMJ ankylosis occurs, it is an extremely disabling affliction that causes 
problems with mastication, digestion, speech, appearance, and access to routine dentistry. It 
also has an impact on the psychological development of the patient with concerns related to 
an inability to open the mouth. Therefore, in patients with ankylosing spondylitis, the total 
replacement of the TMJ with an alloplastic joint system has become the treatment of choice. 
These allow closer reproduction of the natural anatomy, avoids donor site morbidity, 
decreases the risk of reankylosis, and reduces operation time. Furthermore, they allow for 
immediate physiotherapy and rehabilitation with consequent increased benefit to the 
patient. [28]. 
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TMJ concepts prosthesis (formerly Techmedica) has up to 17 years follow-up with 90% 
success rates [29]. These are computer-aided design/computer-aided manufacture 
(CAD/CAM) custom-made prostheses constructed on a stereolithographic model following 
a 3D CT scan. The glenoid fossa component is constructed from titanium mesh bonded to 
the articular surface of high-molecular-weight polyethylene. The condylar component head 
is cobalt-chrome alloy, and the remainder of the body is titanium and is secured to the 
ramus of the mandible by screws. Lorenz also makes a stock prosthesis with similar 
components to the TMJ concepts prosthesis. Whichever operative strategy is employed, it is 
important to note that these techniques all rely on aggressive postoperative physiotherapy 










Fig. 6. Dental panoramic view showing bilateral TMJ replacement with TMJ prostheses in 
AS patient. 
10. Discussion  
Ankyolosing spondylitis has the tendency to involve fibro cartilaginous structures such as 
symphysis pubis, intervertibral discs, sternomanubrial and sternoclavicular joints. The 
involvement of TMJ has not been very well investigated and its incidence is disputed. 
Former studies have reported the involvement of the TMJ in AS between 4% and 32%. 
However, these studies were either only radiological [31] or used only insufficient clinical 
[32] or radiological [33] examination methods. Ehrlich (1930) reported on 753 cases, where  
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Fig. 7. Postero-Anterior (PA) mandible view showing total TMJ replacement using TMJ 
concepts prostheses.  
he found 124 patients (16.5%). forestier et al (1951) found TMJ involvement in 6% of 200 
patients. Nagel (1968) reviewed 1000 patients in which TMJ involvement was only 1%. [17] 
Due disparity in clinical and radiological signs suggests that the TMJ rarely seems to be a 
severe problem for AS patients. It is felt that most TMJ symptoms may be secondary to 
muscle spasm, occlusal factors, and postural imbalance [34], and the literature is only 
sparsely populated with cases of true ankylosis of TMJ secondary to AS.  
11. Conclusion 
In conclusion we recommend routine clinical examinations of TMJ in patients with AS to 
detect rare complications like severe trismus and ankylosis. Both pharmacological and non 
pharmacological modalities are found to be effective in the treatment of AS of TMJ 
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depending on the time and progression.   One should have high index of suspicion of TMJ 
ankylosis in AS for an early detection.  This could avoid the need of expensive and 
technique sensitive joint surgeries. Complementary explorations like joint lavage or 
arthroscopy should be undertaken in ankylosing spondylitis patients with clinical 
symptoms suggestive of TMJ lesions in order to establish the diagnosis and initiate 
treatment and avoid the development of ankylosis forms. 
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